March
2014
What is the future of IP protection during state procurement of drugs?
VEGAS LEX_Legal Alert_(eng)_3_03_2014
Download fileFile added | 23.09.2015 |
Presentation | .pdf (624 Кб) |
<img width="323" src="http://old.vegaslex.ru/data/2014/03/20/1234639770/IP%20drugs.jpg" height="457"> <p> We would like to offer you an analytical survey of VEGAS LEX on "<strong><span style="color: #1f497d;">Protection of intellectual rights to drugs</span>.<span style="color: #1f497d;"> The trends in court practice".</span></strong> </p> <p> <span style="color: #e36c0a;">In our latest issue:</span> </p> <p> The supplier of the generic drug was denied by the auction committee for the right to enter into government contract for supply of the drug with an unexpired patent on an active ingredient owned by the developer of the original drug. </p> <ul> <li>The positions of the Federal Antimonopoly Service of Russia and courts</li> <li>The prospective developments in the practice of intellectual rights in the pharmaceutical sector</li> </ul> <p> <span style="color: #595959;">The analytical survey of VEGAS LEX is an information periodical of law firm VEGAS LEX the main purpose of which is to inform the readers about the recent changers in legislation, court practice and other significant legal issues of business operation.</span> </p>